November 30, 2008 DiagnosticImaging.com. PET/CT in prostate cancer influences staging, treatment strategy By Shalmali Pal Prostate-specific antigen measurements are considered a useful organ-specific marker, but they are not necessarily an adequate tumor marker. PET/CT in combination with PSA levels can play a significant role in detecting and staging prostate cancer, according to two presentations Sunday at RSNA 2008. Dr. Nghi Nguyen presented his multi-institutional group's work on the utility of PET/CT in staging and restaging prostate cancer. Nguyen is from St. Louis University Hospital, where the research was conducted. The study's lead author, Dr. Kahlid Taalab Jr., is now based in Cairo.
![](https://storage.ning.com/topology/rest/1.0/file/get/396595535?profile=original)
See full article and related articles at DiagnosticImaging.com
This article was republished with permission from CMPMedica, LLC
You need to be a member of radRounds Radiology Network to add comments!
Join radRounds Radiology Network